Howell Moffett

3.0k total citations · 1 hit paper
20 papers, 2.3k citations indexed

About

Howell Moffett is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, Howell Moffett has authored 20 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 7 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Howell Moffett's work include Immune Cell Function and Interaction (9 papers), MicroRNA in disease regulation (6 papers) and HIV Research and Treatment (5 papers). Howell Moffett is often cited by papers focused on Immune Cell Function and Interaction (9 papers), MicroRNA in disease regulation (6 papers) and HIV Research and Treatment (5 papers). Howell Moffett collaborates with scholars based in United States, France and Netherlands. Howell Moffett's co-authors include Sirkka B. Stephan, Matthias T. Stephan, Smitha P.S. Pillai, Laura E. McKnight, Carl D. Novina, Martin E. Wohlfahrt, Weihang Ji, Philip J. Norris, Cary F. Opel and Venu G. Pillarisetty and has published in prestigious journals such as Science, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Howell Moffett

20 papers receiving 2.2k citations

Hit Papers

In situ programming of le... 2017 2026 2020 2023 2017 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Howell Moffett 1.1k 957 823 467 289 20 2.3k
David G. Gonzalez 1.1k 1.1× 962 1.0× 571 0.7× 335 0.7× 93 0.3× 36 2.9k
Johann Meyer 562 0.5× 2.8k 3.0× 863 1.0× 304 0.7× 1.3k 4.6× 46 3.9k
Quanming Shi 586 0.6× 1.4k 1.5× 768 0.9× 512 1.1× 212 0.7× 28 2.9k
Ryan Basom 725 0.7× 1.0k 1.1× 818 1.0× 121 0.3× 190 0.7× 48 2.2k
Jane Lebkowski 773 0.7× 4.2k 4.4× 755 0.9× 756 1.6× 1.1k 3.7× 91 5.7k
Federico Gonzãlez 1.1k 1.1× 4.4k 4.6× 492 0.6× 385 0.8× 776 2.7× 44 5.8k
Shlomo Nedvetzki 586 0.6× 1.0k 1.1× 268 0.3× 174 0.4× 76 0.3× 24 2.0k
Carole Masurier 798 0.8× 2.0k 2.1× 492 0.6× 154 0.3× 962 3.3× 23 2.7k
Alessandra Recchia 502 0.5× 2.1k 2.2× 825 1.0× 164 0.4× 1.4k 4.8× 45 3.3k
Larry A. Couture 367 0.3× 2.1k 2.2× 505 0.6× 412 0.9× 1.3k 4.5× 46 3.4k

Countries citing papers authored by Howell Moffett

Since Specialization
Citations

This map shows the geographic impact of Howell Moffett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howell Moffett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howell Moffett more than expected).

Fields of papers citing papers by Howell Moffett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howell Moffett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howell Moffett. The network helps show where Howell Moffett may publish in the future.

Co-authorship network of co-authors of Howell Moffett

This figure shows the co-authorship network connecting the top 25 collaborators of Howell Moffett. A scholar is included among the top collaborators of Howell Moffett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Howell Moffett. Howell Moffett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shabaneh, Tamer B., et al.. (2022). Safety switch optimization enhances antibody-mediated elimination of CAR T cells. PubMed. 2. 1026474–1026474. 8 indexed citations
2.
Moffett, Howell, et al.. (2019). B cells engineered to express pathogen-specific antibodies protect against infection. Science Immunology. 4(35). 90 indexed citations
3.
Moffett, Howell, Sirkka B. Stephan, Cary F. Opel, et al.. (2017). Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors. Journal of Clinical Investigation. 127(6). 2176–2191. 262 indexed citations
4.
Moffett, Howell, Michael Coon, Stefan Radtke, et al.. (2017). Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers. Nature Communications. 8(1). 389–389. 143 indexed citations
5.
Stephan, Sirkka B., Howell Moffett, Laura E. McKnight, et al.. (2017). In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers. Nature Nanotechnology. 12(8). 813–820. 571 indexed citations breakdown →
6.
Moffett, Howell, Adam N.R. Cartwright, Hye‐Jung Kim, et al.. (2017). The microRNA miR-31 inhibits CD8+ T cell function in chronic viral infection. Nature Immunology. 18(7). 791–799. 53 indexed citations
7.
Kim, Hye‐Jung, R. Anthony Barnitz, Taras Kreslavsky, et al.. (2015). Stable inhibitory activity of regulatory T cells requires the transcription factor Helios. Science. 350(6258). 334–339. 287 indexed citations
8.
Traeger, Lindsay L., Jeremy D. Volkening, Howell Moffett, et al.. (2015). Unique patterns of transcript and miRNA expression in the South American strong voltage electric eel (Electrophorus electricus). BMC Genomics. 16(1). 243–243. 15 indexed citations
9.
Gallant, Jason R., Lindsay L. Traeger, Jeremy D. Volkening, et al.. (2014). Genomic basis for the convergent evolution of electric organs. Science. 344(6191). 1522–1525. 138 indexed citations
10.
Li, Shuqiang, Howell Moffett, Jun Lü, et al.. (2011). MicroRNA Expression Profiling Identifies Activated B Cell Status in Chronic Lymphocytic Leukemia Cells. PLoS ONE. 6(3). e16956–e16956. 63 indexed citations
11.
Cosmopoulos, Katherine, D. Michiel Pegtel, Jared B. Hawkins, et al.. (2008). Comprehensive Profiling of Epstein-Barr Virus MicroRNAs in Nasopharyngeal Carcinoma. Journal of Virology. 83(5). 2357–2367. 139 indexed citations
12.
Love, Tara M., Howell Moffett, & Carl D. Novina. (2008). Not miR-ly small RNAs: Big potential for microRNAs in therapy. Journal of Allergy and Clinical Immunology. 121(2). 309–319. 50 indexed citations
13.
Moffett, Howell & Carl D. Novina. (2007). A small RNA makes a Bic difference. Genome Biology. 8(7). 221–221. 19 indexed citations
14.
Feng, Jianwen A., et al.. (2005). Convergence on a Distinctive Assembly Mechanism by Unrelated Families of Activating Immune Receptors. Immunity. 22(4). 427–438. 64 indexed citations
15.
Norris, Philip J., Jennifer D. Stone, John W. Heitman, et al.. (2005). Antagonism of HIV-specific CD4+ T cells by C-terminal truncation of a minimum epitope. Molecular Immunology. 43(9). 1349–1357. 12 indexed citations
16.
Norris, Philip J., Howell Moffett, Christian Brander, et al.. (2004). Fine Specificity and Cross-Clade Reactivity of HIV Type 1 Gag-Specific CD4 + T Cells. AIDS Research and Human Retroviruses. 20(3). 315–325. 26 indexed citations
17.
SenGupta, Devi, Philip J. Norris, Todd J. Suscovich, et al.. (2004). Heat Shock Protein-Mediated Cross-Presentation of Exogenous HIV Antigen on HLA Class I and Class II. The Journal of Immunology. 173(3). 1987–1993. 61 indexed citations
18.
Norris, Philip J., Howell Moffett, Otto O. Yang, et al.. (2004). Beyond Help: Direct Effector Functions of Human Immunodeficiency Virus Type 1-Specific CD4+T Cells. Journal of Virology. 78(16). 8844–8851. 77 indexed citations
19.
Norris, Philip J., Marina Sumaroka, Christian Brander, et al.. (2001). Multiple Effector Functions Mediated by Human Immunodeficiency Virus-Specific CD4+T-Cell Clones. Journal of Virology. 75(20). 9771–9779. 57 indexed citations
20.
Khursigara, Gus, John Bertin, Hiroko Yano, et al.. (2001). A Prosurvival Function for the p75 Receptor Death Domain Mediated via the Caspase Recruitment Domain Receptor-Interacting Protein 2. Journal of Neuroscience. 21(16). 5854–5863. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026